These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 30517302)

  • 61. MGMT -535G>T polymorphism is associated with prognosis for patients with metastatic colorectal cancer treated with oxaliplatin-based chemotherapy.
    Park JH; Kim NS; Park JY; Chae YS; Kim JG; Sohn SK; Moon JH; Kang BW; Ryoo HM; Bae SH; Choi GS; Jun SH
    J Cancer Res Clin Oncol; 2010 Aug; 136(8):1135-42. PubMed ID: 20091185
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitative assessment of the association between XPG Asp1104His polymorphism and bladder cancer risk.
    Liu C; Yin Q; Hu J; Weng J; Wang Y
    Tumour Biol; 2014 Feb; 35(2):1203-9. PubMed ID: 24061640
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Genetic polymorphism of XRCC1 correlated with response to oxaliplatin-based chemotherapy in advanced colorectal cancer.
    Lv H; Li Q; Qiu W; Xiang J; Wei H; Liang H; Sui A; Liang J
    Cancer Invest; 2013 Jan; 31(1):24-8. PubMed ID: 23327191
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic Association between the XPG Asp1104His Polymorphism and Head and Neck Cancer Susceptibility: Evidence Based on a Meta-Analysis.
    Jiang HY; Zeng Y; Xu WD; Liu C; Wang YJ; Wang YD; Wang YD
    Asian Pac J Cancer Prev; 2015; 16(9):3645-51. PubMed ID: 25987016
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Association of
    Wang XQ; Terry PD; Li Y; Zhang Y; Kou WJ; Wang MX
    World J Gastroenterol; 2019 Sep; 25(34):5152-5161. PubMed ID: 31558863
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polymorphisms in nucleotide excision repair genes and susceptibility to colorectal cancer in the Polish population.
    Paszkowska-Szczur K; Scott RJ; Górski B; Cybulski C; Kurzawski G; Dymerska D; Gupta S; van de Wetering T; Masojć B; Kashyap A; Gapska P; Gromowski T; Kładny J; Lubiński J; Dębniak T
    Mol Biol Rep; 2015 Mar; 42(3):755-64. PubMed ID: 25391773
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Correlation of XPC Ala499Val and Lys939Gln polymorphisms to risks of esophageal squamous cell carcinoma and gastric cardiac adenocarcinoma].
    Zhou RM; Li Y; Wang N; Zhang XJ; Dong XJ; Guo W
    Ai Zheng; 2006 Sep; 25(9):1113-9. PubMed ID: 16965652
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Nucleotide Excision Repair Gene ERCC2 and ERCC5 Variants Increase Risk of Uterine Cervical Cancer.
    Joo J; Yoon KA; Hayashi T; Kong SY; Shin HJ; Park B; Kim YM; Hwang SH; Kim J; Shin A; Kim JY
    Cancer Res Treat; 2016 Apr; 48(2):708-14. PubMed ID: 26130668
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Role of DNA repair gene polymorphisms in the efficiency of platinum-based adjuvant chemotherapy for non-small cell lung cancer.
    Mathiaux J; Le Morvan V; Pulido M; Jougon J; Bégueret H; Robert J
    Mol Diagn Ther; 2011 Jun; 15(3):159-66. PubMed ID: 21766907
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Modulation of DNA damage by XPF, XPG and ERCC1 gene polymorphisms in pesticide-exposed agricultural workers of Punjab, North-West India.
    Kaur K; Kaur R
    Mutat Res Genet Toxicol Environ Mutagen; 2021; 861-862():503302. PubMed ID: 33551103
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Relationships between genetic polymorphisms and anticancer drug cytotoxicity vis-à-vis the NCI-60 panel.
    Le Morvan V; Bellott R; Moisan F; Mathoulin-Pélissier S; Bonnet J; Robert J
    Pharmacogenomics; 2006 Sep; 7(6):843-52. PubMed ID: 16981845
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Excision repair cross-complementation group 1 codon 118 polymorphism, micro ribonucleic acid and protein expression, clinical outcome of the advanced gastric cancer response to first-line FOLFOX-4 in Qinghai-Tibetan plateau population.
    Qi YJ; Cui S; Yang YZ; Han JQ; Cai BJ; Sheng CF; Ma Y; Wuren T; Ge RL
    J Cancer Res Ther; 2013; 9(3):410-5. PubMed ID: 24125975
    [TBL] [Abstract][Full Text] [Related]  

  • 73. ERCC5 is a novel biomarker of ovarian cancer prognosis.
    Walsh CS; Ogawa S; Karahashi H; Scoles DR; Pavelka JC; Tran H; Miller CW; Kawamata N; Ginther C; Dering J; Sanada M; Nannya Y; Slamon DJ; Koeffler HP; Karlan BY
    J Clin Oncol; 2008 Jun; 26(18):2952-8. PubMed ID: 18565881
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cis-acting genetic variation at an E2F1/YY1 response site and putative p53 site is associated with altered allele-specific expression of ERCC5 (XPG) transcript in normal human bronchial epithelium.
    Blomquist TM; Crawford EL; Willey JC
    Carcinogenesis; 2010 Jul; 31(7):1242-50. PubMed ID: 20233728
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The 5'UTR variant of ERCC5 fails to influence outcomes in ovarian and lung cancer patients undergoing treatment with platinum-based drugs.
    Rulli E; Guffanti F; Caiola E; Ganzinelli M; Damia G; Garassino MC; Piva S; Ceppi L; Broggini M; Marabese M
    Sci Rep; 2016 Dec; 6():39217. PubMed ID: 27966655
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Effect of DPYD, MTHFR, ABCB1, XRCC1, ERCC1 and GSTP1 on chemotherapy related toxicity in colorectal carcinoma.
    Puerta-García E; Urbano-Pérez D; Carrasco-Campos MI; Pérez-Ramírez C; Segura-Pérez A; Calleja-Hernández ; Cañadas-Garre M
    Surg Oncol; 2020 Dec; 35():388-398. PubMed ID: 33035787
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lack of association between ERCC5 gene polymorphisms and gastric cancer risk in a Chinese population.
    Lu JJ; Zhang HQ; Mai P; Ma X; Chen X; Yang YX; Zhang LP
    Genet Mol Res; 2016 Jun; 15(2):. PubMed ID: 27323158
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic significance of excision repair cross complementation group 1 rs2298881 in patients with gastric cancer receiving platinum-based chemotherapy: A PRISMA-compliant meta-analysis.
    Lv Y; Xu M; Sun Y; Liu Y; Zhao L; Liu X; Li Z; Shi G; Jia J; Bi L; Ma N; Zhang X; Qi C
    Medicine (Baltimore); 2021 Aug; 100(33):e26850. PubMed ID: 34414935
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Correlations between microsatellite instability, ERCC1/XRCC1 polymorphism and clinical characteristics, and FOLFOX adjuvant chemotherapy effect of colorectal cancer patients.
    Zhang L; Zhao J; Yu B; Song X; Sun G; Han L; Wang L; Dong S
    Cancer Genet; 2017 Dec; 218-219():51-57. PubMed ID: 29153096
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
    Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
    Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.